A detailed history of Tillman Hartley LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tillman Hartley LLC holds 536 shares of VRTX stock, worth $241,398. This represents 0.07% of its overall portfolio holdings.

Number of Shares
536
Previous 536 -0.0%
Holding current value
$241,398
Previous $251 Million 0.78%
% of portfolio
0.07%
Previous 0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $183,848 - $220,124
536 New
536 $218 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tillman Hartley LLC Portfolio

Follow Tillman Hartley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tillman Hartley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tillman Hartley LLC with notifications on news.